{"url":"https://lda.senate.gov/api/v1/filings/a7e51fdf-c458-4d4b-bd29-da4b376de0a2/","filing_uuid":"a7e51fdf-c458-4d4b-bd29-da4b376de0a2","filing_type":"RR","filing_type_display":"Registration","filing_year":2021,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a7e51fdf-c458-4d4b-bd29-da4b376de0a2/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Andrew Womack","dt_posted":"2021-11-15T18:18:32-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 East Middlefield Road","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Mountain View","registrant_state":"CA","registrant_zip":"94043","registrant":{"id":401106312,"url":"https://lda.senate.gov/api/v1/registrants/401106312/","house_registrant_id":null,"name":"IGM BIOSCIENCES, INC.","description":"​Development of engineered IgM antibodies","address_1":"325 East Middlefield Road","address_2":null,"address_3":null,"address_4":null,"city":"Mountain View","state":"CA","state_display":"California","zip":"94043","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANDREW WOMACK","contact_telephone":"+1 650-965-7873","dt_updated":"2025-07-20T14:43:22.033084-04:00"},"client":{"id":212724,"url":"https://lda.senate.gov/api/v1/clients/212724/","client_id":12,"name":"IGM BIOSCIENCES, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-10-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to the development of antibody therapy for COVID-19","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":138239,"prefix":"mr","prefix_display":"MR.","first_name":"ANDREW","nickname":null,"middle_name":"WESLEY","last_name":"WOMACK","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"TOPSE HOLDING A/S","contribution":"0.00","ownership_percentage":"39.00","address":"Haldor Topses Alle 1, 2800 Kgs","city":"Lyngby","state":null,"state_display":null,"country":"DK","country_display":"Denmark","ppb_city":null,"ppb_state":null,"ppb_state_display":null,"ppb_country":"DK","ppb_country_display":"Denmark"}],"affiliated_organizations":[{"name":"IGM INFECTIOUS DISEASES, INC.","url":null,"address_1":"325 East Middlefield Road","address_2":null,"address_3":null,"address_4":null,"city":"Mountain View","state":"CA","state_display":"California","zip":"94043","country":"US","country_display":"United States of America","ppb_city":null,"ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America"},{"name":"IGM AUTOIMMUNITY AND INFLAMMATION, INC.","url":null,"address_1":"325 East Middlefield Road","address_2":null,"address_3":null,"address_4":null,"city":"Mountain View","state":"CA","state_display":"California","zip":"94043","country":"US","country_display":"United States of America","ppb_city":null,"ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America"}]}